Abstract
Currently, there are no clinical trials evaluating the role of nebulized ketamine in managing pain in the Pediatric ED. Our aim was to assess and compare the analgesic efficacy and rates of adverse effects of ketamine administered via breath-actuated nebulizer at three different dosing regimens (0.75mg/kg, 1 mg/kg and 1.5 mg/kg) for emergency department pediatric patients presenting with acute and chronic painful conditions.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
